Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.

Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. We …

Trusted by top hospitals around the world, industry-leading Masimo Signal Extraction Technology ® overcomes the limitations of conventional pulse oximetry to perform accurately and reliably during …

Learn about Masimo’s mission, values, and breakthroughs in patient monitoring and medical technology, driving innovation and improving care worldwide.

Feb 17, 2026 · Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher …

Masimo Contact Us - We welcome your feedback! If you have a question, comment or concern, please complete the form below and we will respond within 2 business days.

Advanced Monitoring Solutions - Masimo’s first breakthrough technology, Signal Extraction Technology® (SET®), overcame the limitations of conventional pulse oximetry with the ability to …

Masimo wearable devices provide freedom for patients and clinicians alike, eliminating physical connections without sacrificing the power of clinically proven Masimo continuous monitoring.

Masimo SET ® pulse oximetry has also been shown to improve patient outcomes by helping clinicians reduce retinopathy of prematurity (ROP) in neonates, screen newborns for critical congenital heart …

Feb 25, 2025 · Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its full-year 2025 guidance. …